Celltrion reported KRW1.35K in EPS Earnings Per Share for its fiscal quarter ending in June of 2026.


Fiscal Calendar Actual Consensus Previous Date
FY2026Q3 Sep/2026 1689.92 1530.51 1128.22 Oct/12
FY2026Q2 Jun/2026 1351.86 1450.51 810.39 Jul/03
FY2026Q1 Mar/2026 1576.11 1216.07 481.37 May/06
FY2025Q4 Dec/2025 2285.89 1401.69 481.37 Feb/05
FY2025Q3 Sep/2025 1128.22 998.38 388.00 Oct/21




Eps Change Date
Akebia Therapeutics USD -0.04 0.04 Dec/2025
Alaunos Therapeutics USD -0.39 0.12 Jun/2026
Avita Medical AUD -0.25 0.13 Jun/2026
Celltrion KRW 1.35K 224.25 Jun/2026
Dianthus Therapeutics USD -0.9 0.05 Jun/2026
Ionis Pharmaceuticals USD 0.66 1.35 Sep/2026
IQVIA Holdings USD 3.34 0.19 Sep/2026
Moderna USD 0.38 2.35 Sep/2026
Organon & Co USD 0.6 0.2 Sep/2026
Revvity USD 1.37 0.04 Sep/2026
Tectonic Therapeutic USD -1.18 0.17 Jun/2026
Viatris USD 0.71 0.02 Sep/2026
Xeris Pharmaceuticals USD -0.18 0.19 Jun/2026